Secondly, hyperuricemia was associated with higher odds of serious hepatic steatosis, elevated ALT and advanced fibrosis in obese NAFLD, whereas the significance was lost in non-obese individuals. This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.